Suppr超能文献

黄色阈下微脉冲激光治疗视网膜疾病:文献的深入分析与综述

Yellow Subthreshold Micropulse Laser in Retinal Diseases: An In-Depth Analysis and Review of the Literature.

作者信息

Iovino Claudio, Iodice Clemente Maria, Pisani Danila, Rosolia Andrea, Testa Francesco, Giannaccare Giuseppe, Chhablani Jay, Simonelli Francesca

机构信息

Eye Clinic, Multidisciplinary Department of Medical, Surgical and Dental Sciences, University of Campania Luigi Vanvitelli, Naples, Italy.

Department of Ophthalmology, University "Magna Graecia", Catanzaro, Italy.

出版信息

Ophthalmol Ther. 2023 Jun;12(3):1479-1500. doi: 10.1007/s40123-023-00698-w. Epub 2023 Mar 18.

Abstract

Yellow subthreshold micropulse laser (YSML) is a retinal laser capable of inducing a biologic response without causing thermal damage to the targeted tissue. The 577-nm YSML is delivered to the retina abiding by different protocols in which wavelength, power, duration, spot size and number of spots can be properly set to achieve the most effective and safe treatment response in various chorioretinal disorders. The ultrashort trains of power modulate the activation of the retinal pigment epithelium cells and intraretinal cells, such as Müller cells, causing no visible retinal scars. Subthreshold energy delivered by YSML stimulates the production of the heat-shock proteins, highly conserved molecules that protect cells against any sort of stress by blocking apoptotic and inflammatory pathways that cause cell damage. YSML treatment allows resorption of the subretinal fluid in central serous chorioretinopathy and intraretinal fluid in various conditions including diabetic macular edema, postoperative cystoid macular edema and other miscellaneous conditions. YSML also seems to modulate the development and progression of reticular pseudodrusen in dry age-related macular degeneration. The aim of this review is to discuss and summarize the safety and efficacy of YSML treatment in retinal diseases.

摘要

黄色阈下微脉冲激光(YSML)是一种视网膜激光,能够诱导生物反应而不会对目标组织造成热损伤。577纳米的YSML通过不同的方案作用于视网膜,在这些方案中,可以适当设置波长、功率、持续时间、光斑大小和光斑数量,以在各种脉络膜视网膜疾病中实现最有效和安全的治疗反应。超短功率脉冲调节视网膜色素上皮细胞和视网膜内细胞(如Müller细胞)的激活,不会产生可见的视网膜瘢痕。YSML传递的阈下能量刺激热休克蛋白的产生,热休克蛋白是高度保守的分子,通过阻断导致细胞损伤的凋亡和炎症途径来保护细胞免受任何形式的应激。YSML治疗可使中心性浆液性脉络膜视网膜病变中的视网膜下液以及包括糖尿病性黄斑水肿、术后囊样黄斑水肿和其他各种情况在内的多种病症中的视网膜内液吸收。YSML似乎还能调节干性年龄相关性黄斑变性中网状假性玻璃膜疣的发展和进展。本综述的目的是讨论和总结YSML治疗视网膜疾病的安全性和有效性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52a6/10164197/bb3a9356ab52/40123_2023_698_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验